
Hypogonadotropic Hypogonadism 15: KAL1, FGFR1, SOX10
When the hypothalamus makes too little GnRH, puberty stalls; this form has been tied to KAL1, FGFR1 and SOX10, with one reported reversal.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

When the hypothalamus makes too little GnRH, puberty stalls; this form has been tied to KAL1, FGFR1 and SOX10, with one reported reversal.

Self-limited delayed puberty can look much like congenital hypogonadotropic hypogonadism; an FGFR1 or FGF8 mutation separates the two.

Precise identification of FGFR1 mutations confirms HH8, separates it from similar disorders and shapes hormone replacement choices and monitoring over time.

Gonadotropin production falters when FGFR1 is altered, delaying puberty and affecting fertility. Diagnosis, hormone care and counseling are described.

Mutations in TNFRSF13B disrupt B-cell development and antibody production; testing confirms IMD23, guides treatment and informs decisions about family planning.

Weakened immune defenses leave people with IMD28 prone to infection; pinpointing the causative mutation supports earlier diagnosis, tailored therapy and carrier testing.

Abnormal immunoglobulins form complexes that settle in the glomeruli, causing inflammation and scarring; genetic analysis can flag predisposition to Ig-MPGN.

Different mutations can produce similar symptoms in IDAR42, so clinical assessment alone may fall short. DNA testing pinpoints the mutation behind the diagnosis.